Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adam Lane
Combined mTOR and MEK Inhibition Is an Effective Therapy in a Novel Mouse Model for Angiosarcoma
Oncotarget
Oncology
Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials
‹
1
2
Related publications
Combined Modality Therapy Improves Overall Survival for Angiosarcoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Combined Modality Therapy Results in Improved Overall Survival for Angiosarcoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
The Novel Sodium Channel Modulator GS-458967 (GS967) Is an Effective Treatment in a Mouse Model of SCN8A Encephalopathy
Epilepsia
Neurology
Combination Therapy With Dendritic Cells and Lenalidomide Is an Effective Approach to Enhance Antitumor Immunity in a Mouse Colon Cancer Model
Oncotarget
Oncology
Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells
Cancer Discovery
Oncology
Equivalent Benefit of mTORC1 Blockade and Combined PI3K-mTOR Blockade in a Mouse Model of Tuberous Sclerosis
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy Against Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma
Kidney International Reports
Nephrology
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology